Scientists at The University of Texas at El Paso have received nearly $6 million from the National Institutes of Health (NIH) to improve treatment and develop new diagnostic tools to assess post-therapeutic outcomes for patients with Chagas disease. Igor Almeida, Ph.D., professor of biological sciences, is the principal investigator (PI) of the award — a five-year grant worth $5,713,730 — from NIH’s National Institute of Allergy and Infectious Diseases.